Lipidomics in drug discovery

被引:18
|
作者
Vihervaara, Terhi
Suoniemi, Matti
Laaksonen, Reijo
机构
[1] Zora Biosciences Oy, Biologinkuja 1
关键词
MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; MOLECULAR LIPIDOMICS; TRIPLE QUADRUPOLE; PROSTATE-CANCER; HUMAN PLASMA; SPHINGOLIPIDS; LIPIDS; ACID; METABOLISM;
D O I
10.1016/j.drudis.2013.09.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipidomics is a rapidly growing technology that can be used in biomedical research to study disease mechanisms, identify novel disease biomarkers and drug efficacy biomarkers, and reveal off-target effects. Lipidomics can also be used to elucidate the mechanism of action of different drug compounds or as readouts in Mendelian randomization approaches. Furthermore, lipidomics can be utilized to identify deviations in metabolic and/or signaling pathways in different stages of disease. Therefore, as we discuss here, this emerging technology also has a substantial potential in various drug discovery programs.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 50 条
  • [21] Application of Sebum Lipidomics to Biomarkers Discovery in Neurodegenerative Diseases
    Briganti, Stefania
    Truglio, Mauro
    Angiolillo, Antonella
    Lombardo, Salvatore
    Leccese, Deborah
    Camera, Emanuela
    Picardo, Mauro
    Di Costanzo, Alfonso
    METABOLITES, 2021, 11 (12)
  • [22] Lipidomics applications for disease biomarker discovery in mammal models
    Zhao, Ying-Yong
    Cheng, Xian-Long
    Lin, Rui-Chao
    Wei, Feng
    BIOMARKERS IN MEDICINE, 2015, 9 (02) : 153 - 168
  • [23] Targeted lipidomics: Discovery of new fatty acyl amides
    Tan, Bo
    Bradshaw, Heather B.
    Rimmerman, Neta
    Srinivasan, Harini
    Yu, Y. William
    Krey, Jocelyn F.
    Monn, M. Francesca
    Chen, Jay Shih-Chieh
    hu, Sherry S-Jung Hu
    Pickens, Sarah R.
    Walker, J. Michael
    AAPS JOURNAL, 2006, 8 (03): : E461 - E465
  • [24] Drug discovery - Drug discovery: Affinity and beyond
    Janjic, N
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (02): : 28 - 28
  • [25] METABOLOMICS/LIPIDOMICS FOR DRUG DEVELOPMENT IN A PHARMACEUTICAL COMPANY
    Satomi, Yoshinori
    DRUG METABOLISM REVIEWS, 2015, 47 : 17 - 17
  • [26] Lipidomics Targeted drug delivery: fat chance?
    Adriaanse, Chris
    CHEMISTRY & INDUSTRY, 2010, (17) : 12 - 12
  • [27] LipidFinder 2.0: advanced informatics pipeline for lipidomics discovery applications
    Alvarez-Jarreta, Jorge
    Rodrigues, Patricia R. S.
    Fahy, Eoin
    O'Connor, Anne
    Price, Anna
    Gaud, Caroline
    Andrews, Simon
    Benton, Paul
    Siuzdak, Gary
    Hawksworth, Jade, I
    Valdivia-Garcia, Maria
    Allen, Stuart M.
    O'Donnell, Valerie B.
    BIOINFORMATICS, 2021, 37 (10) : 1478 - 1479
  • [28] An update on lipidomics: Progress and application in biomarker and drug development
    Han, Xianlin
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (06) : 586 - 591
  • [29] Drug discovery
    Kennedy, D
    SCIENCE, 2004, 303 (5665) : 1729 - 1729
  • [30] DRUG DISCOVERY
    Thayer, Ann
    CHEMICAL & ENGINEERING NEWS, 2008, 86 (43) : 9 - 9